Real-World Pharmacovigilance Analysis of Adverse Events Associated with Liposomal Bupivacaine and Bupivacaine
This study identified unexpected AEs associated with liposomal bupivacaine and bupivacaine. Physicians must exercise particular caution when administering liposomal bupivacaine due to its associated risks. Monitoring for delayed analgesia-related AEs may enhance the safe use of this medication for pain management.
Authors
- Shouming Chen (ORCID: https://orcid.org/0000-0003-2050-7565)
- Xi Chen (ORCID: https://orcid.org/0009-0002-4302-5710)
- Dongxu Chen (ORCID: https://orcid.org/0000-0002-1414-3163)
- Yi Da Wang
Institutions
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
Publication Details
- Journal
- Journal of Pain Research
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/jpr.s519504
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 0.00